Follicle Biology Laboratory, Center for Reproductive Medicine, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.
Hum Reprod Update. 2010 Jul-Aug;16(4):395-414. doi: 10.1093/humupd/dmp056. Epub 2010 Feb 1.
BACKGROUND Female cancer patients are offered 'banking' of gametes before starting fertility-threatening cancer therapy. Transplants of fresh and frozen ovarian tissue between healthy fertile and infertile women have demonstrated the utility of the tissue banked for restoration of endocrine and fertility function. Additional methods, like follicle culture and isolated follicle transplantation, are in development. METHODS Specialist reproductive medicine scientists and clinicians with complementary expertise in ovarian tissue culture and transplantation presented relevant published literature in their field of expertise and also unpublished promising data for discussion. As the major aims were to identify the current gaps prohibiting advancement, to share technical experience and to orient new research, contributors were allowed to provide their opinioned expert views on future research. RESULTS Normal healthy children have been born in cancer survivors after orthotopic transplantation of their cryopreserved ovarian tissue. Longevity of the graft might be optimized by using new vitrification techniques and by promoting rapid revascularization of the graft. For the in vitro culture of follicles, a successive battery of culture methods including the use of defined media, growth factors and three-dimensional extracellular matrix support might overcome growth arrest of the follicles. Molecular methods and immunoassay can evaluate stage of maturation and guide adequate differentiation. Large animals, including non-human primates, are essential working models. CONCLUSIONS Experiments on ovarian tissue from non-human primate models and from consenting fertile and infertile patients benefit from a multidisciplinary approach. The new discipline of oncofertility requires professionalization, multidisciplinarity and mobilization of funding for basic and translational research.
女性癌症患者在开始威胁生育的癌症治疗前,可选择进行配子“保存”。在健康有生育能力的女性和不孕女性之间进行新鲜和冷冻卵巢组织移植,已经证明了组织库用于恢复内分泌和生育功能的效用。其他方法,如卵泡培养和分离卵泡移植,正在开发中。
具有卵巢组织培养和移植专业知识的生殖医学专家和临床医生,根据其专业领域的相关文献和未发表的有前途的数据进行了讨论。由于主要目的是确定目前阻碍进展的空白,分享技术经验并指导新的研究,因此允许贡献者就未来的研究提供他们有意见的专家观点。
在对冷冻保存的卵巢组织进行原位移植后,癌症幸存者中已经诞生了正常健康的儿童。通过使用新的玻璃化技术和促进移植物的快速再血管化,可以优化移植物的寿命。对于卵泡的体外培养,一系列培养方法,包括使用定义的培养基、生长因子和三维细胞外基质支持,可能会克服卵泡的生长停滞。分子方法和免疫测定可以评估成熟阶段,并指导适当的分化。大型动物,包括非人类灵长类动物,是必不可少的工作模型。
来自非人类灵长类动物模型和有生育能力的同意患者和不孕患者的卵巢组织实验受益于多学科方法。肿瘤生育新学科需要专业化、多学科和动员资金用于基础和转化研究。